semaglutide for perimenopause weight gain Menopausal & Semaglutide: What Works Semaglutide for Menopausal Weight Gain:

10.1038/s41366-021-00955-7 52 PotilinskiM

References Han, S

Developed by Theratechnologies Inc., it underwent phase II trials in the mid-2000s for GH deficiency (GHD) and HIV lipodystrophy but was discontinued, with reported reasons including hypersensitivity reactions, including an anaphylaxis-like reaction in one trial participant Wong et al (2008) [Note: Abstract only

It is a prescription-only drug that is indicated for managing HSDD in premenopausal women , but it can also be prescribed off-label in men and women with other sexual problems

Discontinuation and Duration Dependent Cardiovascular Risk Compared with continual use of GLP-1s, discontinuing treatment for 6 months was associated with a 4% increased risk of major adverse cardiovascular events